{"id":68287,"date":"2019-07-29T12:55:11","date_gmt":"2019-07-29T04:55:11","guid":{"rendered":"http:\/\/facfox.com\/news\/aerospace\/collplant-reports-q3-fy2018-results-reinforces-commitment-to-3d-bioprinter-materials.3dm"},"modified":"2019-07-29T12:55:11","modified_gmt":"2019-07-29T04:55:11","slug":"collplant-reports-q3-fy2018-results-reinforces-commitment-to-3d-bioprinter-materials","status":"publish","type":"post","link":"https:\/\/facfox.com\/news\/collplant-reports-q3-fy2018-results-reinforces-commitment-to-3d-bioprinter-materials\/","title":{"rendered":"Collplant reports Q3 FY2018 results, reinforces commitment to 3D bioprinter materials"},"content":{"rendered":"<div id=\"dpsp-content-top\" class=\"dpsp-content-wrapper dpsp-shape-rectangular dpsp-size-medium dpsp-has-spacing dpsp-has-buttons-count dpsp-show-on-mobile dpsp-button-style-1\">\n<ul class=\"dpsp-networks-btns-wrapper dpsp-networks-btns-content dpsp-networks-btns-share dpsp-column-auto\">\n<li><span class=\"dpsp-network-icon\"><\/span><span class=\"dpsp-network-label-wrapper\"><\/span><\/li>\n<li><span class=\"dpsp-network-icon\"><\/span><span class=\"dpsp-network-label-wrapper\"><\/span><\/li>\n<li><span class=\"dpsp-network-icon\"><\/span><span class=\"dpsp-network-label-wrapper\"><\/span><\/li>\n<li><span class=\"dpsp-network-icon\"><\/span><span class=\"dpsp-network-label-wrapper\"><\/span><\/li>\n<\/ul>\n<\/div>\n<p>Regenerative medicine company and 3D bioprinter material developer Collplant (NASDAQ:CLGN) , has reported its financial results for the third quarter of 2018. Headline revenue for the three months ended September 30, 2018 was $224,000, a 209% increase on the same period in 2017, which was $73,000. The increase is reflective of the growing commercialization of the company&#8217;s proprietary materials.<\/p>\n<p>In a press release on the financial report Yehiel Tal, CollPlant CEO, commented, &#8220;During the third quarter we made progress advancing our other 3D bioprinting business. We are moving forward with our development activities with various companies that are using CollPlant&#8217;s rhCollagen based BioInk for the bioprinting of organs and tissues.&#8221;<\/p>\n<p><strong>Living biomaterials, extracted from tobacco plants<\/strong><\/p>\n<p>At present, Collplant is in the market with three materials:<\/p>\n<p>&#8211; VergenixSTR, a soft tissue repair gel designed to form a metric for Platelet Rich Plasma (PRP), and treat chronic tendon and ligament disorders.<\/p>\n<p>&#8211; VergenixFG, a collagen gel for addition to bandages and improving wound care.<\/p>\n<p>&#8211; And it rhCollagen bioink, its primary solution for 3D bioprinting with live cell content for which it has a separate development division.<\/p>\n<p>The rhCollagen bioink is grown and harvested from tobacco plants bioengineered with DNA to create live collagen. rhCollagen is also to be used in a newly-formed lung bioprinting project between CollPlant and United Therapeutics Corporation. As an aside United Therapeutics Corporation&#8217;s subsidiary Lung Biotechnology PBC that is working on this project with CollPlant, also has a 3D bioprinting agreement in place with 3D Systems.<\/p>\n<figure id=\"attachment_123098\" style=\"width: 970px\" class=\"wp-caption aligncenter\"><img fetchpriority=\"high\" decoding=\"async\" class=\"size-full wp-image-123098\" src=\"https:\/\/3dprintingindustry.com\/wp-content\/uploads\/2017\/10\/collplantbioink.jpg\" alt=\"Graphic demonstration of 3D bioprinting with rhCollagen bio-ink. Image via CollPlant.\" width=\"970\" height=\"698\" srcset=\"https:\/\/3dprintingindustry.com\/wp-content\/uploads\/2017\/10\/collplantbioink.jpg 970w, https:\/\/3dprintingindustry.com\/wp-content\/uploads\/2017\/10\/collplantbioink-770x554.jpg 770w, https:\/\/3dprintingindustry.com\/wp-content\/uploads\/2017\/10\/collplantbioink-200x144.jpg 200w, https:\/\/3dprintingindustry.com\/wp-content\/uploads\/2017\/10\/collplantbioink-500x360.jpg 500w\" sizes=\"(max-width: 970px) 100vw, 970px\" \/><figcaption class=\"wp-caption-text\">Graphic demonstration of 3D bioprinting with rhCollagen bio-ink. Image via CollPlant.<\/figcaption><\/figure>\n<p><strong>Driven by collagen sales in America<\/strong><\/p>\n<p>According to the Q3 FY2018 report, this quarter&#8217;s revenues were dominated by European sales of CollPlant&#8217;s VergenixSTR material, and rhCollagen sales in America.<\/p>\n<p>Operating expenses in Q3 FY2018 have risen in comparison to last year, from $1.1 million to $1.7 million. This rise has been primarily attributed to an increase in salaries and share expenses. Of the $1.7 million operating cost for Q3 2018, general, administrative and marketing costs equate to $748 thousand. The company has also spent more on research and development in this quarter than in Q3 2017. Net research and development expenses for Q3 2018 were reported at $941 thousand, compared to $740 thousand for the same period in 2017.<\/p>\n<figure id=\"attachment_144741\" style=\"width: 1024px\" class=\"wp-caption aligncenter\"><img decoding=\"async\" class=\"size-large wp-image-144741\" src=\"https:\/\/3dprintingindustry.com\/wp-content\/uploads\/2018\/11\/Screen-Shot-2018-11-30-at-12.17.09-1024x614.png\" alt=\"CollPlant CONDENSED CONSOLIDATED INTERIM STATEMENTS OF COMPREHENSIVE LOSS (UNAUDITED) for Q3 2018 Image via CollPlant Investors\" width=\"1024\" height=\"614\" srcset=\"https:\/\/3dprintingindustry.com\/wp-content\/uploads\/2018\/11\/Screen-Shot-2018-11-30-at-12.17.09-1024x614.png 1024w, https:\/\/3dprintingindustry.com\/wp-content\/uploads\/2018\/11\/Screen-Shot-2018-11-30-at-12.17.09-770x461.png 770w, https:\/\/3dprintingindustry.com\/wp-content\/uploads\/2018\/11\/Screen-Shot-2018-11-30-at-12.17.09-200x120.png 200w, https:\/\/3dprintingindustry.com\/wp-content\/uploads\/2018\/11\/Screen-Shot-2018-11-30-at-12.17.09-500x300.png 500w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><figcaption class=\"wp-caption-text\">Extract from CollPlant Q3 2018 financial statements. Image via CollPlant Investors<\/figcaption><\/figure>\n<p>The CollPlant Third Quarter 2018 Financial Results report, including results for the first nine months of 2018, can be found online here.<\/p>\n<p>In closing comment on the report, Tal stated, &#8220;Based on our work with major market players in the fields of 3D bioprinting and medical aesthetics, we believe that CollPlant&#8217;s rhCollagen is the ideal building block for regenerative medicine scaffolds available today, and will play a critical role in those markets.&#8221;<\/p>\n<p><em>Featured image shows Professor Oded Shoseyov, founder of CollPlant Holdings Ltd. Photo via jewishbusinessnews<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Regenerative medicine company and 3D bioprinter material developer Collplant (NASDAQ:CLGN) , has reported its financial results for the third quarter of 2018. Headline revenue for the three months ended September 30, 2018 was $224,000, a 209% increase on the same period in 2017, which was $73,000. The increase is reflective of the growing commercialization of [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":182452,"comment_status":"open","ping_status":"close","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"fifu_image_url":"https:\/\/3dprintingindustry.com\/wp-content\/uploads\/2017\/10\/collplantbioink.jpg","fifu_image_alt":"","footnotes":""},"categories":[53],"tags":[169,170,173],"class_list":["post-68287","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-aerospace","tag-3dprint","tag-3dprinting","tag-business"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.2 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Collplant reports Q3 FY2018 results, reinforces commitment to 3D bioprinter materials - FacFox News<\/title>\n<meta name=\"description\" content=\"Regenerative medicine company and 3D bioprinter material developer Collplant (NASDAQ:CLGN) , has reported its financial results for the third quarter of\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/facfox.com\/news\/collplant-reports-q3-fy2018-results-reinforces-commitment-to-3d-bioprinter-materials\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Collplant reports Q3 FY2018 results, reinforces commitment to 3D bioprinter materials\" \/>\n<meta property=\"og:description\" content=\"Regenerative medicine company and 3D bioprinter material developer Collplant (NASDAQ:CLGN) , has reported its financial results for the third quarter of\" \/>\n<meta property=\"og:url\" content=\"https:\/\/facfox.com\/news\/collplant-reports-q3-fy2018-results-reinforces-commitment-to-3d-bioprinter-materials\/\" \/>\n<meta property=\"og:site_name\" content=\"FacFox News\" \/>\n<meta property=\"article:published_time\" content=\"2019-07-29T04:55:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/3dprintingindustry.com\/wp-content\/uploads\/2017\/10\/collplantbioink.jpg\" \/>\n<meta name=\"author\" content=\"edi\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/3dprintingindustry.com\/wp-content\/uploads\/2017\/10\/collplantbioink.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"edi\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/facfox.com\/news\/collplant-reports-q3-fy2018-results-reinforces-commitment-to-3d-bioprinter-materials\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/facfox.com\/news\/collplant-reports-q3-fy2018-results-reinforces-commitment-to-3d-bioprinter-materials\/\"},\"author\":{\"name\":\"edi\",\"@id\":\"https:\/\/facfox.com\/news\/#\/schema\/person\/30c6618bf20fcdd6af222ac673dfd857\"},\"headline\":\"Collplant reports Q3 FY2018 results, reinforces commitment to 3D bioprinter materials\",\"datePublished\":\"2019-07-29T04:55:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/facfox.com\/news\/collplant-reports-q3-fy2018-results-reinforces-commitment-to-3d-bioprinter-materials\/\"},\"wordCount\":471,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/facfox.com\/news\/#organization\"},\"image\":{\"@id\":\"https:\/\/facfox.com\/news\/collplant-reports-q3-fy2018-results-reinforces-commitment-to-3d-bioprinter-materials\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/3dprintingindustry.com\/wp-content\/uploads\/2017\/10\/collplantbioink.jpg\",\"keywords\":[\"3dprint\",\"3dprinting\",\"business\"],\"articleSection\":[\"Aerospace\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/facfox.com\/news\/collplant-reports-q3-fy2018-results-reinforces-commitment-to-3d-bioprinter-materials\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/facfox.com\/news\/collplant-reports-q3-fy2018-results-reinforces-commitment-to-3d-bioprinter-materials\/\",\"url\":\"https:\/\/facfox.com\/news\/collplant-reports-q3-fy2018-results-reinforces-commitment-to-3d-bioprinter-materials\/\",\"name\":\"Collplant reports Q3 FY2018 results, reinforces commitment to 3D bioprinter materials - FacFox News\",\"isPartOf\":{\"@id\":\"https:\/\/facfox.com\/news\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/facfox.com\/news\/collplant-reports-q3-fy2018-results-reinforces-commitment-to-3d-bioprinter-materials\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/facfox.com\/news\/collplant-reports-q3-fy2018-results-reinforces-commitment-to-3d-bioprinter-materials\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/3dprintingindustry.com\/wp-content\/uploads\/2017\/10\/collplantbioink.jpg\",\"datePublished\":\"2019-07-29T04:55:11+00:00\",\"description\":\"Regenerative medicine company and 3D bioprinter material developer Collplant (NASDAQ:CLGN) , has reported its financial results for the third quarter of\",\"breadcrumb\":{\"@id\":\"https:\/\/facfox.com\/news\/collplant-reports-q3-fy2018-results-reinforces-commitment-to-3d-bioprinter-materials\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/facfox.com\/news\/collplant-reports-q3-fy2018-results-reinforces-commitment-to-3d-bioprinter-materials\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/facfox.com\/news\/collplant-reports-q3-fy2018-results-reinforces-commitment-to-3d-bioprinter-materials\/#primaryimage\",\"url\":\"https:\/\/3dprintingindustry.com\/wp-content\/uploads\/2017\/10\/collplantbioink.jpg\",\"contentUrl\":\"https:\/\/3dprintingindustry.com\/wp-content\/uploads\/2017\/10\/collplantbioink.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/facfox.com\/news\/collplant-reports-q3-fy2018-results-reinforces-commitment-to-3d-bioprinter-materials\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/facfox.com\/news\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Collplant reports Q3 FY2018 results, reinforces commitment to 3D bioprinter materials\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/facfox.com\/news\/#website\",\"url\":\"https:\/\/facfox.com\/news\/\",\"name\":\"FacFox News\",\"description\":\"News and Insights of 3D Printing and Manufacturing\",\"publisher\":{\"@id\":\"https:\/\/facfox.com\/news\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/facfox.com\/news\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/facfox.com\/news\/#organization\",\"name\":\"FacFox News\",\"url\":\"https:\/\/facfox.com\/news\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/facfox.com\/news\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/facfox.com\/news\/wp-content\/uploads\/2020\/11\/facfox-news-homepg-logo-200px.png\",\"contentUrl\":\"https:\/\/facfox.com\/news\/wp-content\/uploads\/2020\/11\/facfox-news-homepg-logo-200px.png\",\"width\":200,\"height\":55,\"caption\":\"FacFox News\"},\"image\":{\"@id\":\"https:\/\/facfox.com\/news\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/facfox.com\/news\/#\/schema\/person\/30c6618bf20fcdd6af222ac673dfd857\",\"name\":\"edi\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/7f64f2d9574372e5e27ea0251aee0b353f2ac65df22b55672ae03a41a20cbbbd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/7f64f2d9574372e5e27ea0251aee0b353f2ac65df22b55672ae03a41a20cbbbd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/7f64f2d9574372e5e27ea0251aee0b353f2ac65df22b55672ae03a41a20cbbbd?s=96&d=mm&r=g\",\"caption\":\"edi\"},\"sameAs\":[\"https:\/\/facfox.com\/news\"],\"url\":\"https:\/\/facfox.com\/news\/author\/edi\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Collplant reports Q3 FY2018 results, reinforces commitment to 3D bioprinter materials - FacFox News","description":"Regenerative medicine company and 3D bioprinter material developer Collplant (NASDAQ:CLGN) , has reported its financial results for the third quarter of","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/facfox.com\/news\/collplant-reports-q3-fy2018-results-reinforces-commitment-to-3d-bioprinter-materials\/","og_locale":"en_US","og_type":"article","og_title":"Collplant reports Q3 FY2018 results, reinforces commitment to 3D bioprinter materials","og_description":"Regenerative medicine company and 3D bioprinter material developer Collplant (NASDAQ:CLGN) , has reported its financial results for the third quarter of","og_url":"https:\/\/facfox.com\/news\/collplant-reports-q3-fy2018-results-reinforces-commitment-to-3d-bioprinter-materials\/","og_site_name":"FacFox News","article_published_time":"2019-07-29T04:55:11+00:00","og_image":[{"url":"https:\/\/3dprintingindustry.com\/wp-content\/uploads\/2017\/10\/collplantbioink.jpg","type":"","width":"","height":""}],"author":"edi","twitter_card":"summary_large_image","twitter_image":"https:\/\/3dprintingindustry.com\/wp-content\/uploads\/2017\/10\/collplantbioink.jpg","twitter_misc":{"Written by":"edi","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/facfox.com\/news\/collplant-reports-q3-fy2018-results-reinforces-commitment-to-3d-bioprinter-materials\/#article","isPartOf":{"@id":"https:\/\/facfox.com\/news\/collplant-reports-q3-fy2018-results-reinforces-commitment-to-3d-bioprinter-materials\/"},"author":{"name":"edi","@id":"https:\/\/facfox.com\/news\/#\/schema\/person\/30c6618bf20fcdd6af222ac673dfd857"},"headline":"Collplant reports Q3 FY2018 results, reinforces commitment to 3D bioprinter materials","datePublished":"2019-07-29T04:55:11+00:00","mainEntityOfPage":{"@id":"https:\/\/facfox.com\/news\/collplant-reports-q3-fy2018-results-reinforces-commitment-to-3d-bioprinter-materials\/"},"wordCount":471,"commentCount":0,"publisher":{"@id":"https:\/\/facfox.com\/news\/#organization"},"image":{"@id":"https:\/\/facfox.com\/news\/collplant-reports-q3-fy2018-results-reinforces-commitment-to-3d-bioprinter-materials\/#primaryimage"},"thumbnailUrl":"https:\/\/3dprintingindustry.com\/wp-content\/uploads\/2017\/10\/collplantbioink.jpg","keywords":["3dprint","3dprinting","business"],"articleSection":["Aerospace"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/facfox.com\/news\/collplant-reports-q3-fy2018-results-reinforces-commitment-to-3d-bioprinter-materials\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/facfox.com\/news\/collplant-reports-q3-fy2018-results-reinforces-commitment-to-3d-bioprinter-materials\/","url":"https:\/\/facfox.com\/news\/collplant-reports-q3-fy2018-results-reinforces-commitment-to-3d-bioprinter-materials\/","name":"Collplant reports Q3 FY2018 results, reinforces commitment to 3D bioprinter materials - FacFox News","isPartOf":{"@id":"https:\/\/facfox.com\/news\/#website"},"primaryImageOfPage":{"@id":"https:\/\/facfox.com\/news\/collplant-reports-q3-fy2018-results-reinforces-commitment-to-3d-bioprinter-materials\/#primaryimage"},"image":{"@id":"https:\/\/facfox.com\/news\/collplant-reports-q3-fy2018-results-reinforces-commitment-to-3d-bioprinter-materials\/#primaryimage"},"thumbnailUrl":"https:\/\/3dprintingindustry.com\/wp-content\/uploads\/2017\/10\/collplantbioink.jpg","datePublished":"2019-07-29T04:55:11+00:00","description":"Regenerative medicine company and 3D bioprinter material developer Collplant (NASDAQ:CLGN) , has reported its financial results for the third quarter of","breadcrumb":{"@id":"https:\/\/facfox.com\/news\/collplant-reports-q3-fy2018-results-reinforces-commitment-to-3d-bioprinter-materials\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/facfox.com\/news\/collplant-reports-q3-fy2018-results-reinforces-commitment-to-3d-bioprinter-materials\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/facfox.com\/news\/collplant-reports-q3-fy2018-results-reinforces-commitment-to-3d-bioprinter-materials\/#primaryimage","url":"https:\/\/3dprintingindustry.com\/wp-content\/uploads\/2017\/10\/collplantbioink.jpg","contentUrl":"https:\/\/3dprintingindustry.com\/wp-content\/uploads\/2017\/10\/collplantbioink.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/facfox.com\/news\/collplant-reports-q3-fy2018-results-reinforces-commitment-to-3d-bioprinter-materials\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/facfox.com\/news\/"},{"@type":"ListItem","position":2,"name":"Collplant reports Q3 FY2018 results, reinforces commitment to 3D bioprinter materials"}]},{"@type":"WebSite","@id":"https:\/\/facfox.com\/news\/#website","url":"https:\/\/facfox.com\/news\/","name":"FacFox News","description":"News and Insights of 3D Printing and Manufacturing","publisher":{"@id":"https:\/\/facfox.com\/news\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/facfox.com\/news\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/facfox.com\/news\/#organization","name":"FacFox News","url":"https:\/\/facfox.com\/news\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/facfox.com\/news\/#\/schema\/logo\/image\/","url":"https:\/\/facfox.com\/news\/wp-content\/uploads\/2020\/11\/facfox-news-homepg-logo-200px.png","contentUrl":"https:\/\/facfox.com\/news\/wp-content\/uploads\/2020\/11\/facfox-news-homepg-logo-200px.png","width":200,"height":55,"caption":"FacFox News"},"image":{"@id":"https:\/\/facfox.com\/news\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/facfox.com\/news\/#\/schema\/person\/30c6618bf20fcdd6af222ac673dfd857","name":"edi","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/7f64f2d9574372e5e27ea0251aee0b353f2ac65df22b55672ae03a41a20cbbbd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/7f64f2d9574372e5e27ea0251aee0b353f2ac65df22b55672ae03a41a20cbbbd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7f64f2d9574372e5e27ea0251aee0b353f2ac65df22b55672ae03a41a20cbbbd?s=96&d=mm&r=g","caption":"edi"},"sameAs":["https:\/\/facfox.com\/news"],"url":"https:\/\/facfox.com\/news\/author\/edi\/"}]}},"fifu_image_url":"https:\/\/3dprintingindustry.com\/wp-content\/uploads\/2017\/10\/collplantbioink.jpg","_links":{"self":[{"href":"https:\/\/facfox.com\/news\/wp-json\/wp\/v2\/posts\/68287","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/facfox.com\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/facfox.com\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/facfox.com\/news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/facfox.com\/news\/wp-json\/wp\/v2\/comments?post=68287"}],"version-history":[{"count":0,"href":"https:\/\/facfox.com\/news\/wp-json\/wp\/v2\/posts\/68287\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/facfox.com\/news\/wp-json\/wp\/v2\/media\/182452"}],"wp:attachment":[{"href":"https:\/\/facfox.com\/news\/wp-json\/wp\/v2\/media?parent=68287"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/facfox.com\/news\/wp-json\/wp\/v2\/categories?post=68287"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/facfox.com\/news\/wp-json\/wp\/v2\/tags?post=68287"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}